By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Bridge Medicines 



New York  New York    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS

Bridge Medicines is a pioneering drug-discovery company focused on advancing promising early technologies in major academic institutions from human proof-of-concept to clinical development. Launched by Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell Medicine and Takeda Pharmaceutical Company Ltd., in partnership with Deerfield Management and Bay City Capital, Bridge Medicines is a groundbreaking initiative that provides an unbroken, fully funded and professionally staffed path from discovery to drug candidate.

YEAR FOUNDED:

October 2016

LEADERSHIP:

CEO: William J. Polvino


Key Statistics


Email:
Ownership: Private

Web Site: Bridge Medicines
Employees:
Symbol: 
 




Segment
Drug Discovery





Company News
//-->